{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T07:04:26Z","timestamp":1778051066429,"version":"3.51.4"},"reference-count":145,"publisher":"Oxford University Press (OUP)","issue":"2","funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Spanish Ministry of Economy and Competitiveness"},{"name":"Fondo Europeo de Desarrollo Regional FEDER"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,3,1]]},"DOI":"10.1093\/humupd\/dmx039","type":"journal-article","created":{"date-parts":[[2017,12,6]],"date-time":"2017-12-06T15:14:39Z","timestamp":1512573279000},"page":"225-241","source":"Crossref","is-referenced-by-count":48,"title":["Combined oral contraceptives and\/or antiandrogens versus insulin sensitizers for polycystic ovary syndrome: a systematic review and meta-analysis"],"prefix":"10.1093","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6002-4237","authenticated-orcid":false,"given":"Manuel","family":"Luque-Ram\u00edrez","sequence":"first","affiliation":[{"name":"Department of Endocrinology & Metabolism, Hospital Universitario Ram\u00f3n y Cajal & Universidad de Alcal\u00e1, E-28034 Madrid, Spain"},{"name":"Diabetes, Obesity and Human Reproduction Research Group, Instituto Ram\u00f3n y Cajal de Investigaci\u00f3n Sanitaria IRYCIS & Centro de Investigaci\u00f3n Biom\u00e9dica en Red Diabetes y Enfermedades Metab\u00f3licas Asociadas CIBERDEM, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00eda","family":"Nattero-Ch\u00e1vez","sequence":"additional","affiliation":[{"name":"Department of Endocrinology & Metabolism, Hospital Universitario Ram\u00f3n y Cajal & Universidad de Alcal\u00e1, E-28034 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9s E","family":"Ortiz Flores","sequence":"additional","affiliation":[{"name":"Department of Endocrinology & Metabolism, Hospital Universitario Ram\u00f3n y Cajal & Universidad de Alcal\u00e1, E-28034 Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9ctor F","family":"Escobar-Morreale","sequence":"additional","affiliation":[{"name":"Department of Endocrinology & Metabolism, Hospital Universitario Ram\u00f3n y Cajal & Universidad de Alcal\u00e1, E-28034 Madrid, Spain"},{"name":"Diabetes, Obesity and Human Reproduction Research Group, Instituto Ram\u00f3n y Cajal de Investigaci\u00f3n Sanitaria IRYCIS & Centro de Investigaci\u00f3n Biom\u00e9dica en Red Diabetes y Enfermedades Metab\u00f3licas Asociadas CIBERDEM, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2017,12,27]]},"reference":[{"key":"key\n\t\t\t\t20180223095042_dmx039C1","first-page":"347","article-title":"Comparison of metformin and cyproteroneestrodiol compound effect on hs c-reactive protein and serum androgen levels in patients with polycystic ovary syndrome","volume":"26","author":"Aghamohammadzadeh","year":"2010","journal-title":"Pak J Med Sci"},{"key":"key\n\t\t\t\t20180223095042_dmx039C2","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1542\/peds.2015-4089","article-title":"Metformin or oral contraceptives for adolescents with polycystic ovarian syndrome: a meta-analysis","volume":"137","author":"Al Khalifah","year":"2016","journal-title":"Pediatrics"},{"key":"key\n\t\t\t\t20180223095042_dmx039C3","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1515\/JPEM.2005.18.8.761","article-title":"Randomized controlled trial evaluating response to metformin versus standard therapy in the treatment of adolescents with polycystic ovary syndrome","volume":"18","author":"Allen","year":"2005","journal-title":"J Pediatr Endocrinol Metab"},{"key":"key\n\t\t\t\t20180223095042_dmx039C4","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1530\/EJE-17-0516","article-title":"Combined oral contraceptives plus spironolactone compared with metformin in women with polycystic ovary syndrome: a randomized clinical trial","volume":"177","author":"Alpa\u00f1\u00e9s","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t20180223095042_dmx039C5","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1515\/jpem-2014-0283","article-title":"Randomized clinical trial evaluating metformin versus oral contraceptive pills in the treatment of adolescents with polycystic ovarian syndrome","volume":"28","author":"Al-Zubeidi","year":"2015","journal-title":"J Pediatr Endocrinol Metab"},{"key":"key\n\t\t\t\t20180223095042_dmx039C6","first-page":"129","article-title":"Metabolic risks at different phenotypes of patients with polycystic ovary syndrome","volume":"32","author":"Andreeva","year":"2016","journal-title":"Gynecol Endocrinol"},{"key":"key\n\t\t\t\t20180223095042_dmx039C7","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jclinepi.2012.03.013","article-title":"GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations","volume":"66","author":"Andrews","year":"2013","journal-title":"J Clin Epidemiol"},{"key":"key\n\t\t\t\t20180223095042_dmx039C8","first-page":"CD004425","article-title":"Combined oral contraceptive pills for treatment of acne","volume":"7","author":"Arowojolu","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t20180223095042_dmx039C9","first-page":"2434","article-title":"A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain","volume":"85","author":"Asuncion","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180223095042_dmx039C10","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.fertnstert.2008.06.035","article-title":"The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report","volume":"91","author":"Azziz","year":"2009","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20180223095042_dmx039C11","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/humupd\/dmu012","article-title":"Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"20","author":"Barry","year":"2014","journal-title":"Hum Reprod Update"},{"key":"key\n\t\t\t\t20180223095042_dmx039C12","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.2169\/internalmedicine.48.2177","article-title":"The effect of ethinylestradiol (EE)\/cyproterone acetate (CA) and EE\/CA plus metformin treatment on adhesion molecules in cases with polycystic ovary syndrome (PCOS)","volume":"48","author":"Bilgir","year":"2009","journal-title":"Intern Med"},{"key":"key\n\t\t\t\t20180223095042_dmx039C13","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3109\/09513590.2012.743007","article-title":"Polycystic ovary syndrome and combined oral contraceptive use: a comparison of clinical practice in the United States to treatment guidelines","volume":"29","author":"Bird","year":"2013","journal-title":"Gynecol Endocrinol"},{"key":"key\n\t\t\t\t20180223095042_dmx039C14","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1210\/jc.2012-3698","article-title":"Global adiposity and thickness of intraperitoneal and mesenteric adipose tissue depots are increased in women with polycystic ovary syndrome (PCOS)","volume":"98","author":"Borruel","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180223095042_dmx039C15","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/humrep\/dew218","article-title":"The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis","volume":"31","author":"Bozdag","year":"2016","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20180223095042_dmx039C16","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s00404-013-2742-y","article-title":"The effects of drospirenone-ethinyl estradiol and drospirenone-ethinyl estradiol + metformin on ovarian ultrasonographic markers, body fat mass index, leptin, and ghrelin","volume":"288","author":"Cakiroglu","year":"2013","journal-title":"Arch Gynecol Obstet"},{"key":"key\n\t\t\t\t20180223095042_dmx039C17","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1093\/humrep\/dew243","article-title":"Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic-hyperinsulinaemic clamp studies","volume":"31","author":"Cassar","year":"2016","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20180223095042_dmx039C18","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.steroids.2013.05.001","article-title":"Androgens inhibit adipogenesis during human adipose stem cell commitment to preadipocyte formation","volume":"78","author":"Chazenbalk","year":"2013","journal-title":"Steroids"},{"key":"key\n\t\t\t\t20180223095042_dmx039C19","doi-asserted-by":"crossref","first-page":"488","DOI":"10.14310\/horm.2002.1553","article-title":"The benefit-to-risk ratio of common treatments in PCOS: effect of oral contraceptives versus metformin on atherogenic markers","volume":"13","author":"Christakou","year":"2014","journal-title":"Hormones (Athens)"},{"key":"key\n\t\t\t\t20180223095042_dmx039C20","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/humrep\/deh588","article-title":"The effect of combination therapy with metformin and combined oral contraceptives (COC) versus COC alone on insulin sensitivity, hyperandrogenaemia, SHBG and lipids in PCOS patients","volume":"20","author":"Cibula","year":"2005","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20180223095042_dmx039C21","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S1470-2045(15)00212-0","article-title":"Endometrial cancer and oral contraceptives: an individual participant meta-analysis of 27 276 women with endometrial cancer from 36 epidemiological studies","volume":"16","author":"Collaborative Group on Epidemiological Studies on Endometrial Cancer","year":"2015","journal-title":"Lancet Oncol"},{"key":"key\n\t\t\t\t20180223095042_dmx039C22","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1530\/EJE-14-0252","article-title":"European survey of diagnosis and management of the polycystic ovary syndrome: results of the ESE PCOS Special Interest Group\u2019s Questionnaire","volume":"171","author":"Conway","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t20180223095042_dmx039C23","doi-asserted-by":"crossref","first-page":"P1","DOI":"10.1530\/EJE-14-0253","article-title":"The polycystic ovary syndrome: a position statement from the European Society of Endocrinology","volume":"171","author":"Conway","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t20180223095042_dmx039C24","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1210\/jc.2007-2429","article-title":"Clinical review: Insulin sensitizers for the treatment of hirsutism: a systematic review and metaanalyses of randomized controlled trials","volume":"93","author":"Cosma","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180223095042_dmx039C25","first-page":"CD005552","article-title":"Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome","volume":"24","author":"Costello","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t20180223095042_dmx039C26","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1055\/s-0033-1363261","article-title":"Effects of metformin or an oral contraceptive containing cyproterone acetate on serum c-reactive protein, interleukin-6 and soluble vascular cell adhesion molecule-1 concentrations in women with polycystic ovary syndrome","volume":"122","author":"Dardzinska","year":"2014","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"key\n\t\t\t\t20180223095042_dmx039C27","first-page":"CD010813","article-title":"Combined oral contraceptives: venous thrombosis","volume":"3","author":"de Bastos","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t20180223095042_dmx039C28","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/jog.12524","article-title":"Comparison of steroidogenic pathways among normoandrogenic and hyperandrogenic polycystic ovary syndrome patients and normal cycling women","volume":"41","author":"de Medeiros","year":"2015","journal-title":"J Obstet Gynaecol Res"},{"key":"key\n\t\t\t\t20180223095042_dmx039C29","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1210\/er.2011-1034","article-title":"Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications","volume":"33","author":"Diamanti-Kandarakis","year":"2012","journal-title":"Endocr Rev"},{"key":"key\n\t\t\t\t20180223095042_dmx039C30","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3109\/09513590.2015.1080679","article-title":"Comparison of spironolactone and spironolactone plus metformin in the treatment of polycystic ovary syndrome","volume":"32","author":"Diri","year":"2016","journal-title":"Gynecol Endocrinol"},{"key":"key\n\t\t\t\t20180223095042_dmx039C31","doi-asserted-by":"crossref","first-page":"4655","DOI":"10.1210\/jc.2013-2385","article-title":"Lifestyle modification programs in polycystic ovary syndrome: systematic review and meta-analysis","volume":"98","author":"Domecq","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180223095042_dmx039C32","doi-asserted-by":"crossref","first-page":"4178","DOI":"10.1210\/jc.2016-2586","article-title":"Hyperandrogenism accompanies increased intra-abdominal fat storage in normal weight polycystic ovary syndrome women","volume":"101","author":"Dumesic","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180223095042_dmx039C33","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1056\/NEJMra041536","article-title":"Polycystic ovary syndrome","volume":"352","author":"Ehrmann","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180223095042_dmx039C34","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1093\/humrep\/17.7.1729","article-title":"Clinical, endocrine and metabolic effects of metformin added to ethinyl estradiol-cyproterone acetate in non-obese women with polycystic ovarian syndrome: a randomized controlled study","volume":"17","author":"Elter","year":"2002","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20180223095042_dmx039C35","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/humupd\/dmr042","article-title":"Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society","volume":"18","author":"Escobar-Morreale","year":"2012","journal-title":"Hum Reprod Update"},{"key":"key\n\t\t\t\t20180223095042_dmx039C36","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.fertnstert.2011.05.091","article-title":"Effect of combined metformin and oral contraceptive therapy on metabolic factors and endothelial function in overweight and obese women with polycystic ovary syndrome","volume":"96","author":"Essah","year":"2011","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20180223095042_dmx039C37","doi-asserted-by":"crossref","first-page":"E1088","DOI":"10.1210\/jc.2013-1295","article-title":"Referral bias in defining the phenotype and prevalence of obesity in polycystic ovary syndrome","volume":"98","author":"Ezeh","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180223095042_dmx039C38","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3109\/09513590.2010.487595","article-title":"The effect of different hormone therapies on anti-mullerian hormone serum levels in anovulatory women of reproductive age","volume":"27","author":"Fabregues","year":"2011","journal-title":"Gynecol Endocrinol"},{"key":"key\n\t\t\t\t20180223095042_dmx039C39","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","article-title":"Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group","volume":"97","author":"Fauser","year":"2012","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20180223095042_dmx039C40","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3109\/09513590.2015.1101441","article-title":"Management of polycystic ovarian syndrome with Diane-35 or Diane-35 plus metformin","volume":"32","author":"Feng","year":"2016","journal-title":"Gynecol Endocrinol"},{"key":"key\n\t\t\t\t20180223095042_dmx039C41","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1016\/j.fertnstert.2009.10.016","article-title":"Comparison of effects of 3 mg drospirenone plus 20 mug ethinyl estradiol alone or combined with metformin or cyproterone acetate on classic metabolic cardiovascular risk factors in nonobese women with polycystic ovary syndrome","volume":"94","author":"Fruzzetti","year":"2010","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20180223095042_dmx039C42","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.2337\/db11-1360","article-title":"Polycystic ovary syndrome is a risk factor for type 2 diabetes: results from a long-term prospective study","volume":"61","author":"Gambineri","year":"2012","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t20180223095042_dmx039C43","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1210\/jc.2005-2250","article-title":"Treatment with flutamide, metformin and their combination added to hypocaloric diet in overweight-obese women with polycystic ovary syndrome: a randomized, 12-month, placebo-controlled study","volume":"91","author":"Gambineri","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180223095042_dmx039C44","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1210\/jc.2003-031780","article-title":"Comparison of efficacy of spironolactone with metformin in the management of polycystic ovary syndrome: an open-labeled study","volume":"89","author":"Ganie","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180223095042_dmx039C45","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1210\/jc.2013-1040","article-title":"Improved efficacy of low-dose spironolactone and metformin combination than either drug alone in the management of women with polycystic ovary syndrome (PCOS): a six-month, open-label randomized study","volume":"98","author":"Ganie","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180223095042_dmx039C46","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1210\/jc.2014-1135","article-title":"Body composition is improved during 12 months\u2019 treatment with metformin alone or combined with oral contraceptives compared with treatment with oral contraceptives in polycystic ovary syndrome","volume":"99","author":"Glintborg","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180223095042_dmx039C47","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s40618-014-0103-8","article-title":"Adiponectin, interleukin-6, monocyte chemoattractant protein-1, and regional fat mass during 12-month randomized treatment with metformin and\/or oral contraceptives in polycystic ovary syndrome","volume":"37","author":"Glintborg","year":"2014","journal-title":"J Endocrinol Invest"},{"key":"key\n\t\t\t\t20180223095042_dmx039C48","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1530\/EC-17-0034","article-title":"Effect of oral contraceptives and\/or metformin on GLP-1 secretion and reactive hypoglycaemia in polycystic ovary syndrome","volume":"6","author":"Glintborg","year":"2017","journal-title":"Endocr Connect"},{"key":"key\n\t\t\t\t20180223095042_dmx039C49","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/j.metabol.2015.06.011","article-title":"Increased thrombin generation in women with polycystic ovary syndrome: a pilot study on the effect of metformin and oral contraceptives","volume":"64","author":"Glintborg","year":"2015","journal-title":"Metabolism"},{"key":"key\n\t\t\t\t20180223095042_dmx039C50","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1056\/NEJM199011153232003","article-title":"The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism","volume":"323","author":"Godsland","year":"1990","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180223095042_dmx039C51","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.4158\/EP15748.DSCPT2","article-title":"American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and Pcos Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome \u2013 Part 2","volume":"21","author":"Goodman","year":"2015","journal-title":"Endocr Pract"},{"key":"key\n\t\t\t\t20180223095042_dmx039C52","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1136\/bmj.39490.551019.BE","article-title":"What is \u2018quality of evidence\u2019 and why is it important to clinicians?","volume":"336","author":"Guyatt","year":"2008","journal-title":"Bmj"},{"key":"key\n\t\t\t\t20180223095042_dmx039C53","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1016\/j.fertnstert.2010.02.041","article-title":"Metformin, naltrexone, or the combination of prednisolone and antiandrogenic oral contraceptives as first-line therapy in hyperinsulinemic women with polycystic ovary syndrome","volume":"94","author":"Hadziomerovic-Pekic","year":"2010","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20180223095042_dmx039C54","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1123\/ijsnem.2013-0232","article-title":"The effect of lifestyle intervention on body composition, glycemic control, and cardiorespiratory fitness in polycystic ovarian syndrome: a systematic review and meta-analysis","volume":"25","author":"Haqq","year":"2015","journal-title":"Int J Sport Nutr Exerc Metab"},{"key":"key\n\t\t\t\t20180223095042_dmx039C55","doi-asserted-by":"crossref","first-page":"4116","DOI":"10.1210\/jc.2003-030424","article-title":"Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome","volume":"88","author":"Harborne","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180223095042_dmx039C56","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1365-2265.2011.04160.x","article-title":"The impact of intensified exercise training on insulin resistance and fitness in overweight and obese women with and without polycystic ovary syndrome","volume":"76","author":"Harrison","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t20180223095042_dmx039C57","author":"Higgins","year":"2011"},{"key":"key\n\t\t\t\t20180223095042_dmx039C58","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ijgo.2009.08.004","article-title":"The role of family history in clinical symptoms and therapeutic outcomes of women with polycystic ovary syndrome","volume":"108","author":"Hu","year":"2010","journal-title":"Int J Gynaecol Obstet"},{"key":"key\n\t\t\t\t20180223095042_dmx039C59","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.2337\/dc07-2265","article-title":"Retinol-binding protein 4 and insulin resistance in polycystic ovary syndrome","volume":"31","author":"Hutchison","year":"2008","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t20180223095042_dmx039C60","doi-asserted-by":"crossref","first-page":"E48","DOI":"10.1210\/jc.2010-0828","article-title":"Effects of exercise on insulin resistance and body composition in overweight and obese women with and without polycystic ovary syndrome","volume":"96","author":"Hutchison","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180223095042_dmx039C61","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1210\/jc.2003-030117","article-title":"Flutamide-metformin therapy to reduce fat mass in hyperinsulinemic ovarian hyperandrogenism: effects in adolescents and in women on third-generation oral contraception","volume":"88","author":"Ibanez","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180223095042_dmx039C62","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1210\/jc.2003-031281","article-title":"Ethinylestradiol-drospirenone, flutamide-metformin, or both for adolescents and women with hyperinsulinemic hyperandrogenism: opposite effects on adipocytokines and body adiposity","volume":"89","author":"Iba\u00f1ez","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180223095042_dmx039C63","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1210\/jc.2004-1405","article-title":"Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of metformin at the start and after more than one year of therapy","volume":"90","author":"Iba\u00f1ez","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180223095042_dmx039C64","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1093\/humrep\/dei072","article-title":"High neutrophil count in girls and women with hyperinsulinaemic hyperandrogenism: normalization with metformin and flutamide overcomes the aggravation by oral contraception","volume":"20","author":"Iba\u00f1ez","year":"2005","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20180223095042_dmx039C65","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/09513590.2010.490612","article-title":"Divergent effects of ethinylestradiol-drospirenone and flutamide-metformin on follistatin in adolescents and women with hyperinsulinemic androgen excess","volume":"27","author":"Ibanez","year":"2011","journal-title":"Gynecol Endocrinol"},{"key":"key\n\t\t\t\t20180223095042_dmx039C66","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1210\/jc.2006-2684","article-title":"Combined low-dose pioglitazone, flutamide, and metformin for women with androgen excess","volume":"92","author":"Ibanez","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180223095042_dmx039C67","doi-asserted-by":"crossref","first-page":"869","DOI":"10.3109\/09513590.2010.487589","article-title":"Low-dose pioglitazone, flutamide, metformin plus an estro-progestagen for non-obese young women with polycystic ovary syndrome: increasing efficacy and persistent safety over 30 months","volume":"26","author":"Ibanez","year":"2010","journal-title":"Gynecol Endocrinol"},{"key":"key\n\t\t\t\t20180223095042_dmx039C68","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-2265.2007.03137.x","article-title":"Pioglitazone (7.5 mg\/day) added to flutamide-metformin in women with androgen excess: additional increments of visfatin and high molecular weight adiponectin","volume":"68","author":"Ibanez","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"key\n\t\t\t\t20180223095042_dmx039C69","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/humrep\/dei329","article-title":"Discontinuous low-dose flutamide-metformin plus an oral or a transdermal contraceptive in patients with hyperinsulinaemic hyperandrogenism: normalizing effects on CRP, TNF-alpha and the neutrophil\/lymphocyte ratio","volume":"21","author":"Ibanez","year":"2006","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20180223095042_dmx039C70","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/ajh\/hpu251","article-title":"Hypertension in reproductive-aged women with polycystic ovary syndrome and association with obesity","volume":"28","author":"Joham","year":"2014","journal-title":"Am J Hypertens"},{"key":"key\n\t\t\t\t20180223095042_dmx039C71","doi-asserted-by":"crossref","first-page":"E447","DOI":"10.1210\/jc.2013-2007","article-title":"Gestational diabetes and type 2 diabetes in reproductive-aged women with polycystic ovary syndrome","volume":"99","author":"Joham","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180223095042_dmx039C72","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/09513590.2015.1006188","article-title":"Metformin improves endothelial function and carotid intima media thickness in patients with PCOS","volume":"31","author":"Kaya","year":"2015","journal-title":"Gynecol Endocrinol"},{"key":"key\n\t\t\t\t20180223095042_dmx039C73","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/09513590.2010.491164","article-title":"Metformin plus oral contraceptive may decrease plasma sCD40 ligand in women with PCOS patients","volume":"27","author":"Kebapcilar","year":"2011","journal-title":"Gynecol Endocrinol"},{"key":"key\n\t\t\t\t20180223095042_dmx039C74","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00404-009-1051-y","article-title":"Comparison of four different treatment regimens on coagulation parameters, hormonal and metabolic changes in women with polycystic ovary syndrome","volume":"281","author":"Kebapcilar","year":"2010","journal-title":"Arch Gynecol Obstet"},{"key":"key\n\t\t\t\t20180223095042_dmx039C75","doi-asserted-by":"crossref","first-page":"622","DOI":"10.3109\/09513590.2010.530706","article-title":"Inflammatory-metabolic parameters in obese and nonobese normoandrogenemic polycystic ovary syndrome during metformin and oral contraceptive treatment","volume":"27","author":"Kilic","year":"2011","journal-title":"Gynecol Endocrinol"},{"key":"key\n\t\t\t\t20180223095042_dmx039C76","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3109\/09513590.2011.569608","article-title":"Fatty acid-binding protein-4 plasma levels are associated to metabolic abnormalities and response to therapy in girls and young women with androgen excess","volume":"27","author":"Lazaro","year":"2011","journal-title":"Gynecol Endocrinol"},{"key":"key\n\t\t\t\t20180223095042_dmx039C77","doi-asserted-by":"crossref","first-page":"4565","DOI":"10.1210\/jc.2013-2350","article-title":"Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline","volume":"98","author":"Legro","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180223095042_dmx039C78","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/humrep\/dei312","article-title":"Rosiglitazone and ethinyl estradiol\/cyproterone acetate as single and combined treatment of overweight women with polycystic ovary syndrome and insulin resistance","volume":"21","author":"Lemay","year":"2006","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20180223095042_dmx039C79","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1056\/NEJMoa1111840","article-title":"Thrombotic stroke and myocardial infarction with hormonal contraception","volume":"366","author":"Lidegaard","year":"2012","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180223095042_dmx039C80","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/humupd\/dms030","article-title":"Overweight, obesity and central obesity in women with the polycystic ovary syndrome: a systematic review and meta-analysis","volume":"18","author":"Lim","year":"2012","journal-title":"Hum Reprod Update"},{"key":"key\n\t\t\t\t20180223095042_dmx039C81","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1467-789X.2012.01053.x","article-title":"The effect of obesity on polycystic ovary syndrome: a systematic review and meta-analysis","volume":"14","author":"Lim","year":"2013","journal-title":"Obes Rev"},{"key":"key\n\t\t\t\t20180223095042_dmx039C82","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.fertnstert.2016.07.1121","article-title":"Phenotypes and body mass in women with polycystic ovary syndrome identified in referral versus unselected populations: systematic review and meta-analysis","volume":"106","author":"Lizneva","year":"2016","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20180223095042_dmx039C83","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1530\/EJE-15-0646","article-title":"Referral bias in female functional hyperandrogenism and polycystic ovary syndrome","volume":"173","author":"Luque-Ramirez","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t20180223095042_dmx039C84","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1210\/jc.2010-2211","article-title":"Role of decreased circulating hepcidin concentrations in the iron excess of women with the polycystic ovary syndrome","volume":"96","author":"Luque-Ram\u00edrez","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180223095042_dmx039C85","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1210\/jc.2007-0282","article-title":"Comparison of ethinyl-estradiol plus cyproterone acetate versus metformin effects on classic metabolic cardiovascular risk factors in women with the polycystic ovary syndrome","volume":"92","author":"Luque-Ram\u00edrez","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180223095042_dmx039C86","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.2337\/dc07-0642","article-title":"The increased body iron stores of obese women with polycystic ovary syndrome are a consequence of insulin resistance and hyperinsulinism, and do not result from reduced menstrual losses","volume":"30","author":"Luque-Ram\u00edrez","year":"2007","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t20180223095042_dmx039C87","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/oby.2008.491","article-title":"Antiandrogenic contraceptives increase serum adiponectin in obese polycystic ovary syndrome patients","volume":"17","author":"Luque-Ram\u00edrez","year":"2008","journal-title":"Obesity (Silver Spring)"},{"key":"key\n\t\t\t\t20180223095042_dmx039C88","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1210\/jc.2007-0190","article-title":"Obesity is the major determinant of the abnormalities in blood pressure found in young women with the polycystic ovary syndrome","volume":"92","author":"Luque-Ram\u00edrez","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180223095042_dmx039C89","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1093\/humrep\/den095","article-title":"Serum uric acid concentration as non-classic cardiovascular risk factor in women with polycystic ovary syndrome (PCOS): effect of treatment with ethinyl-estradiol plus cyproterone acetate versus metformin","volume":"23","author":"Luque-Ram\u00edrez","year":"2008","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20180223095042_dmx039C90","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1055\/s-0030-1262855","article-title":"Treatment of polycystic ovary syndrome (PCOS) with metformin ameliorates insulin resistance in parallel with the decrease of serum interleukin-6 concentrations","volume":"42","author":"Luque-Ramirez","year":"2011","journal-title":"Horm Metab Res"},{"key":"key\n\t\t\t\t20180223095042_dmx039C91","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1517\/14728222.2015.1075511","article-title":"Targets to treat androgen excess in polycystic ovary syndrome","volume":"19","author":"Luque-Ramirez","year":"2015","journal-title":"Expert Opin Ther Targets"},{"key":"key\n\t\t\t\t20180223095042_dmx039C92","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/HYPERTENSIONAHA.113.02468","article-title":"Office blood pressure, ambulatory blood pressure monitoring, and echocardiographic abnormalities in women with polycystic ovary syndrome: role of obesity and androgen excess","volume":"63","author":"Luque-Ram\u00edrez","year":"2014","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20180223095042_dmx039C93","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1016\/j.fertnstert.2008.03.082","article-title":"Effects of metformin versus ethinyl-estradiol plus cyproterone acetate on ambulatory blood pressure monitoring and carotid intima media thickness in women with the polycystic ovary syndrome","volume":"91","author":"Luque-Ram\u00edrez","year":"2009","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20180223095042_dmx039C94","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1530\/EJE-08-0725","article-title":"Effects of an antiandrogenic oral contraceptive pill compared with metformin on blood coagulation tests and endothelial function in women with the polycystic ovary syndrome: influence of obesity and smoking","volume":"160","author":"Luque-Ram\u00edrez","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t20180223095042_dmx039C95","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/BF02873575","article-title":"Effects of metformin combined with cyproterone acetate on clinical features, endocrine and metabolism of non-obese women with polycystic ovarian syndrome","volume":"25","author":"Lv","year":"2005","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"key\n\t\t\t\t20180223095042_dmx039C96","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1210\/jc.2010-2279","article-title":"Coagulation and fibrinolytic disturbances in women with polycystic ovary syndrome","volume":"96","author":"Manneras-Holm","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180223095042_dmx039C97","doi-asserted-by":"crossref","first-page":"E388","DOI":"10.1210\/jc.2012-3414","article-title":"Evidence for masculinization of adipokine gene expression in visceral and subcutaneous adipose tissue of obese women with polycystic ovary syndrome (PCOS)","volume":"98","author":"Mart\u00ednez-Garc\u00eda","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180223095042_dmx039C98","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.numecd.2013.04.016","article-title":"In PCOS patients the addition of low-dose spironolactone induces a more marked reduction of clinical and biochemical hyperandrogenism than metformin alone","volume":"24","author":"Mazza","year":"2014","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"key\n\t\t\t\t20180223095042_dmx039C99","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4103\/1735-1995.177354","article-title":"Comparison of the effects of metformin, flutamide plus oral contraceptives, and simvastatin on the metabolic consequences of polycystic ovary syndrome","volume":"21","author":"Mehrabian","year":"2016","journal-title":"J Res Med Sci"},{"key":"key\n\t\t\t\t20180223095042_dmx039C100","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2337\/dc06-0618","article-title":"Effects of medical therapy on insulin resistance and the cardiovascular system in polycystic ovary syndrome","volume":"30","author":"Meyer","year":"2007","journal-title":"Diabetes Care"},{"key":"key\n\t\t\t\t20180223095042_dmx039C101","doi-asserted-by":"crossref","first-page":"S95","DOI":"10.1016\/j.dsx.2015.10.001","article-title":"A comparative study to illustrate the benefits of using ethinyl estradiol-cyproterone acetate over metformin in patients with polycystic ovarian syndrome","volume":"10","author":"Mhao","year":"2016","journal-title":"Diabetes Metab Syndr"},{"key":"key\n\t\t\t\t20180223095042_dmx039C102","doi-asserted-by":"crossref","first-page":"920","DOI":"10.3109\/09513590.2011.564685","article-title":"The effect of a combination therapy with myo-inositol and a combined oral contraceptive pill versus a combined oral contraceptive pill alone on metabolic, endocrine, and clinical parameters in polycystic ovary syndrome","volume":"27","author":"Minozzi","year":"2011","journal-title":"Gynecol Endocrinol"},{"key":"key\n\t\t\t\t20180223095042_dmx039C103","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ejogrb.2004.06.035","article-title":"Combined use of metformin and ethinyl estradiol-cyproterone acetate in polycystic ovary syndrome","volume":"118","author":"Mitkov","year":"2005","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"key\n\t\t\t\t20180223095042_dmx039C104","doi-asserted-by":"crossref","first-page":"E628","DOI":"10.1210\/jc.2012-3908","article-title":"Divergences in insulin resistance betwen the different phenotypes of the polycystic ovary syndrome","volume":"98","author":"Moghetti","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180223095042_dmx039C105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"key\n\t\t\t\t20180223095042_dmx039C106","first-page":"CD007506","article-title":"Lifestyle changes in women with polycystic ovary syndrome","volume":"6","author":"Moran","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t20180223095042_dmx039C107","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1093\/humupd\/dmq001","article-title":"Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis","volume":"16","author":"Moran","year":"2010","journal-title":"Hum Reprod Update"},{"key":"key\n\t\t\t\t20180223095042_dmx039C108","article-title":"Efficacy and safety of myo-inositol supplementation in the treatment of obese hirsute PCOS women: comparative evaluation with OCP+bicalutamide therapy","volume":"37","author":"Moretti","year":"2016","journal-title":"Endocr Rev"},{"key":"key\n\t\t\t\t20180223095042_dmx039C109","doi-asserted-by":"crossref","first-page":"4649","DOI":"10.1210\/jc.2002-021688","article-title":"Metformin reduces serum C-reactive protein levels in women with polycystic ovary syndrome","volume":"88","author":"Morin-Papunen","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180223095042_dmx039C110","first-page":"3161","article-title":"Endocrine and metabolic effects of metformin versus ethinyl estradiol-cyproterone acetate in obese women with polycystic ovary syndrome: a randomized study","volume":"85","author":"Morin-Papunen","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180223095042_dmx039C111","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1210\/jc.2002-020997","article-title":"Metformin versus ethinyl estradiol-cyproterone acetate in the treatment of nonobese women with polycystic ovary syndrome: a randomized study","volume":"88","author":"Morin-Papunen","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180223095042_dmx039C112","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1177\/1933719113488444","article-title":"Effects of drospirenone-ethinylestradiol and\/or metformin on CD4(+)CD28(null) T lymphocytes frequency in women with hyperinsulinemia having polycystic ovary syndrome: a randomized clinical trial","volume":"20","author":"Moro","year":"2013","journal-title":"Reprod Sci"},{"key":"key\n\t\t\t\t20180223095042_dmx039C113","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3109\/09513590.2013.769515","article-title":"Serum free fatty acid levels in PCOS patients treated with glucophage, magnesium oxide and spironolactone","volume":"29","author":"Muneyyirci-Delale","year":"2013","journal-title":"Gynecol Endocrinol"},{"key":"key\n\t\t\t\t20180223095042_dmx039C114","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/humupd\/dmv025","article-title":"Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis","volume":"21","author":"Naderpoor","year":"2016","journal-title":"Hum Reprod Update"},{"key":"key\n\t\t\t\t20180223095042_dmx039C115","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3109\/09513590.2010.521265","article-title":"Effect of ethinylestradiol\/cyproterone acetate on endothelial function in young non-obese women with polycystic ovary syndrome: a pilot study","volume":"27","author":"Naka","year":"2011","journal-title":"Gynecol Endocrinol"},{"key":"key\n\t\t\t\t20180223095042_dmx039C116","author":"National Institute of Health","year":"2012"},{"key":"key\n\t\t\t\t20180223095042_dmx039C117","first-page":"15","article-title":"Effect of short-term standard therapeutic regimens on neuropeptide Y and adipose tissue hormones in overweight insulin-resistant women with polycystic ovary syndrome","volume":"53","author":"Orbetzova","year":"2011","journal-title":"Folia Med (Plovdiv)"},{"key":"key\n\t\t\t\t20180223095042_dmx039C118","doi-asserted-by":"crossref","first-page":"3206872","DOI":"10.1155\/2016\/3206872","article-title":"Different effects of myoinositol plus folic acid versus combined oral treatment on androgen levels in PCOS women","volume":"2016","author":"Ozay","year":"2016","journal-title":"Int J Endocrinol"},{"key":"key\n\t\t\t\t20180223095042_dmx039C119","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.atherosclerosis.2007.12.054","article-title":"Metformin and oral contraceptive treatments reduced circulating asymmetric dimethylarginine (ADMA) levels in patients with polycystic ovary syndrome (PCOS)","volume":"200","author":"Ozgurtas","year":"2008","journal-title":"Atherosclerosis"},{"key":"key\n\t\t\t\t20180223095042_dmx039C120","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/humupd\/dmv029","article-title":"Pregnancy complications in women with polycystic ovary syndrome","volume":"21","author":"Palomba","year":"2015","journal-title":"Hum Reprod Update"},{"key":"key\n\t\t\t\t20180223095042_dmx039C121","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3109\/09513590.2010.507283","article-title":"The impact of oral contraceptives and metformin on anti-Mullerian hormone serum levels in women with polycystic ovary syndrome and biochemical hyperandrogenemia","volume":"27","author":"Panidis","year":"2011","journal-title":"Gynecol Endocrinol"},{"key":"key\n\t\t\t\t20180223095042_dmx039C122","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1210\/er.2012-1003","article-title":"Cardiometabolic aspects of the polycystic ovary syndrome","volume":"33","author":"Randeva","year":"2012","journal-title":"Endocr Rev"},{"key":"key\n\t\t\t\t20180223095042_dmx039C123","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1530\/eje.1.01840","article-title":"Effects of metformin and ethinyl estradiol-cyproterone acetate on lipid levels in obese and non-obese women with polycystic ovary syndrome","volume":"152","author":"Rautio","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t20180223095042_dmx039C124","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS consensus workshop group","year":"2004","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20180223095042_dmx039C125","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/09513590400004736","article-title":"Metformin versus flutamide in the treatment of metabolic consequences of non-obese young women with polycystic ovary syndrome: a randomized prospective study","volume":"19","author":"Sahin","year":"2004","journal-title":"Gynecol Endocrinol"},{"key":"key\n\t\t\t\t20180223095042_dmx039C126","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1093\/humrep\/des028","article-title":"Prevalence of functional disorders of androgen excess in unselected premenopausal women: a study in blood donors","volume":"27","author":"Sanchon","year":"2012","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20180223095042_dmx039C127","doi-asserted-by":"crossref","first-page":"e0182412","DOI":"10.1371\/journal.pone.0182412","article-title":"Exploring factors related to changes in body composition, insulin sensitivity and aerobic capacity in response to a 12-week exercise intervention in overweight and obese women with and without polycystic ovary syndrome","volume":"12","author":"Scott","year":"2017","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180223095042_dmx039C128","doi-asserted-by":"crossref","first-page":"g7647","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"349","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"key":"key\n\t\t\t\t20180223095042_dmx039C129","first-page":"QC13","article-title":"Comparing the effects of agnugol and metformin on oligomenorrhea in patients with polycystic ovary syndrome: a randomized clinical trial","volume":"10","author":"Shayan","year":"2016","journal-title":"J Clin Diagn Res"},{"key":"key\n\t\t\t\t20180223095042_dmx039C130","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.beem.2012.09.004","article-title":"Characteristics and metabolic effects of estrogen and progestins contained in oral contraceptive pills","volume":"27","author":"Sitruk-Ware","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180223095042_dmx039C131","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5152\/jtgga.2016.16129","article-title":"Comparison of efficacy of metformin and oral contraceptive combination of ethinyl estradiol and drospirenone in polycystic ovary syndrome","volume":"17","author":"Suvarna","year":"2016","journal-title":"J Turk Ger Gynecol Assoc"},{"key":"key\n\t\t\t\t20180223095042_dmx039C132","first-page":"CD003053","article-title":"Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility","volume":"16","author":"Tang","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t20180223095042_dmx039C133","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.fertnstert.2008.09.034","article-title":"Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy","volume":"93","author":"Teede","year":"2010","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20180223095042_dmx039C134","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.5694\/mja11.10915","article-title":"Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline","volume":"195","author":"Teede","year":"2011","journal-title":"Med J Aust"},{"key":"key\n\t\t\t\t20180223095042_dmx039C135","first-page":"CD010334","article-title":"Interventions for hirsutism (excluding laser and photoepilation therapy alone)","volume":"4","author":"van Zuuren","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"key\n\t\t\t\t20180223095042_dmx039C136","doi-asserted-by":"crossref","first-page":"883","DOI":"10.4103\/0366-6999.179783","article-title":"Comparison of drospirenone- with cyproterone acetate-containing oral contraceptives, combined with metformin and lifestyle modifications in women with polycystic ovary syndrome and metabolic disorders: a prospective randomized control trial","volume":"129","author":"Wang","year":"2016","journal-title":"Chin Med J (Engl)"},{"key":"key\n\t\t\t\t20180223095042_dmx039C137","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1530\/EJE-11-0616","article-title":"A clinical study on the short-term effect of berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary syndrome","volume":"166","author":"Wei","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t20180223095042_dmx039C138","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.tem.2006.01.003","article-title":"Human ovarian theca cells in culture","volume":"17","author":"Wickenheisser","year":"2006","journal-title":"Trends Endocrinol Metab"},{"key":"key\n\t\t\t\t20180223095042_dmx039C139","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.fertnstert.2010.12.027","article-title":"Lipid levels in polycystic ovary syndrome: systematic review and meta-analysis","volume":"95","author":"Wild","year":"2011","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20180223095042_dmx039C140","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1080\/09513590802217027","article-title":"Effects of metformin and ethinyl estradiol-cyproterone acetate on clinical, endocrine and metabolic factors in women with polycystic ovary syndrome","volume":"24","author":"Wu","year":"2008","journal-title":"Gynecol Endocrinol"},{"key":"key\n\t\t\t\t20180223095042_dmx039C141","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.2337\/db13-1514","article-title":"Obesity-induced infertility and hyperandrogenism are corrected by deletion of the insulin receptor in the ovarian theca cell","volume":"63","author":"Wu","year":"2014","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t20180223095042_dmx039C142","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1210\/jc.2014-3196","article-title":"Approach to the patient: contraception in women with polycystic ovary syndrome","volume":"100","author":"Yildiz","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20180223095042_dmx039C143","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.1093\/humrep\/des232","article-title":"Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria","volume":"27","author":"Yildiz","year":"2012","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20180223095042_dmx039C144","first-page":"377","volume-title":"Polycystic Ovary Syndrome","author":"Zawadzki","year":"1992"},{"key":"key\n\t\t\t\t20180223095042_dmx039C145","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/humupd\/dmt038","article-title":"The effect of combined oral contraception on testosterone levels in healthy women: a systematic review and meta-analysis","volume":"20","author":"Zimmerman","year":"2014","journal-title":"Hum Reprod Update"}],"container-title":["Human Reproduction Update"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/humupd\/article-pdf\/24\/2\/225\/24149695\/dmx039.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T03:50:46Z","timestamp":1751082646000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humupd\/article\/24\/2\/225\/4779919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,27]]},"references-count":145,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2017,12,27]]},"published-print":{"date-parts":[[2018,3,1]]}},"URL":"https:\/\/doi.org\/10.1093\/humupd\/dmx039","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732393395.793559357","asserted-by":"object"}]},"ISSN":["1355-4786","1460-2369"],"issn-type":[{"value":"1355-4786","type":"print"},{"value":"1460-2369","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,3]]},"published":{"date-parts":[[2017,12,27]]}}}